For patients with non-large vessel occlusion, acute ischemic stroke and salvageable brain tissue, intravenous tenecteplase ...

The World Health Organization in 2023 advised against using nonsugar sweeteners for weight control due to a lack of long-term ...

A study adds to growing evidence emphasizing the cardiovascular benefits of the Mediterranean diet, as findings suggest that ...

A neuroprotective agent improved 90-day functional outcomes and reduced poststroke depression and anxiety in patients with ischemic stroke.

AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...

The PSD-95 inhibitor also had a favorable safety profile in phase III trial ...

This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...

The rationale behind the treatment is that, because genetic FXI deficiency has been linked with reduced risk of ischemic ...

NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone ...

A high-dose rehabilitation therapy improves motor outcomes in infants with perinatal stroke, offering rare evidence to guide ...

Bayer has linked asundexian to a 26% reduction in stroke in a phase 3 study, setting the bar for Bristol Myers Squibb and ...

Ever wondered what an ischemic stroke is? And why it can be harmful?An ischemic stroke happens when an artery supplying blood ...